Baseclick and Tebubio Join Forces to Revolutionize Nucleic Acid Bioconjugation and labeling
This partnership represents a significant milestone in advancing the field of nucleic acid bioconjugation and labeling, providing researchers with unprecedented access to cutting-edge tools and solutions. With baseclick's expertise in click chemistry and Tebubio's extensive portfolio of high-quality reagents, the collaboration aims to provide scientists with tailored solutions for precise and efficient nucleic acid modification.
"We are excited to partner with Tebubio to bring our innovative nucleic acid labeling technologies and products to researchers in France," said Dr. Thomas Frischmuth CEO of Baseclick. "This collaboration underscores our commitment advancing scientific discovery by providing researchers with the tools they need."
baseclick's portfolio of nucleic acid labelling solutions complements Tebubio's extensive experience in life science research, enabling researchers to leverage a wide range of applications such as PCR, in situ hybridisation, RNA/DNA detection and more.
Romain Goulay (CSO, Tebubio) says “We’re pleased to welcome baseclick as a partner of Tebubio and look forward to providing researchers throughout Europe and the UK access to these exciting new labeling technologies.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.